MSB 7.69% $1.19 mesoblast limited

Cell Therapy News/Articles, page-6000

  1. 5,631 Posts.
    lightbulb Created with Sketch. 2034

    The more optimistic (100 percent) data was limited to treatments reviewed by the ODAC (Oncologic Drugs Advisory Committee)
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.